Monthly Archives: June 2014

NeuralStem and the ‘Right-To Try’

Colorado has recently passed ‘Right-to-Try’ (RTT) legislation permitting companies to offer experimental treatments for fatal diseases that have not been FDA approved—and the requirement of payment is permitted if the Company so chooses. The criterion is that they have reached … Continue reading

Posted in BioFollies, Biotech, Muddled Media | Tagged , , , | Leave a comment

Opioids and the ‘Right’ to Pain-Free Living

(from  NeuroPerspective June 2014, focused on Pain) Two California counties (Santa Clara and Orange) have filed suit against the pharmaceutical companies with the largest stakes in opioid analgesics (Actavis, Endo, Janssen/JNJ, Purdue Pharma,  Teva Pharma), claiming that they deliberately understated … Continue reading

Posted in Big Pharma, Muddled Media | Tagged , , , | Leave a comment

When It’s Too Good to be True…..

Affiris‘ announcement that one of the two placebos they used in their AD02 antibody trial outperformed everything–including AD02–in stabilizing cognition and hippocampal volume takes Alzheimer’s drug development to a new level of BizarroWorld surprise. Just to recap: They reported that … Continue reading

Posted in Uncategorized | 1 Comment

Valeant Masses Tanks at Allergan Border, Says Prepared to Protect Shareholder Rights

Reading today’s comments by Pershing Square‘s William Ackman  about his plan to remove Allergan directors and replace them with Valeant friendly directors who would support the surrender of Allergan to Valeant, we couldn’t help but be reminded of a recent … Continue reading

Posted in Uncategorized | Leave a comment